261 related articles for article (PubMed ID: 17440063)
1. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
Rosenberg DW; Yang S; Pleau DC; Greenspan EJ; Stevens RG; Rajan TV; Heinen CD; Levine J; Zhou Y; O'Brien MJ
Cancer Res; 2007 Apr; 67(8):3551-4. PubMed ID: 17440063
[TBL] [Abstract][Full Text] [Related]
2. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.
Chan TL; Zhao W; Leung SY; Yuen ST;
Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809
[TBL] [Abstract][Full Text] [Related]
3. BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
Beach R; Chan AO; Wu TT; White JA; Morris JS; Lunagomez S; Broaddus RR; Issa JP; Hamilton SR; Rashid A
Am J Pathol; 2005 Apr; 166(4):1069-75. PubMed ID: 15793287
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
Spring KJ; Zhao ZZ; Karamatic R; Walsh MD; Whitehall VL; Pike T; Simms LA; Young J; James M; Montgomery GW; Appleyard M; Hewett D; Togashi K; Jass JR; Leggett BA
Gastroenterology; 2006 Nov; 131(5):1400-7. PubMed ID: 17101316
[TBL] [Abstract][Full Text] [Related]
5. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
6. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity.
Srivastava A; Redston M; Farraye FA; Yantiss RK; Odze RD
Am J Surg Pathol; 2008 Feb; 32(2):296-303. PubMed ID: 18223333
[TBL] [Abstract][Full Text] [Related]
7. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
8. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
[TBL] [Abstract][Full Text] [Related]
9. Pathologic features and biologic importance of colorectal serrated polyps.
Vakiani E; Yantiss RK
Adv Anat Pathol; 2009 Mar; 16(2):79-91. PubMed ID: 19550369
[TBL] [Abstract][Full Text] [Related]
10. Somatic BRAF-V600E mutations in familial colorectal cancer.
Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
[TBL] [Abstract][Full Text] [Related]
11. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
[TBL] [Abstract][Full Text] [Related]
12. Deletion mutation of BRAF in a serrated adenoma from a patient with familial adenomatous polyposis.
Lee EJ; Park CK; Kim JW; Chang DK; Kim KM
APMIS; 2007 Aug; 115(8):982-6. PubMed ID: 17696956
[TBL] [Abstract][Full Text] [Related]
13. [Colorectal serrated lesions: current insight on their role in colorectal carcinogenesis].
Mäkinen M
Duodecim; 2010; 126(17):2002-11. PubMed ID: 21053517
[TBL] [Abstract][Full Text] [Related]
14. Hyperplastic polyps identified during screening endoscopy: reevaluated by histological examinations and genetic alterations.
Lin YC; Chiu HM; Lee YC; Shun CT; Wang HP; Wu MS
J Formos Med Assoc; 2014 Jul; 113(7):417-21. PubMed ID: 24961182
[TBL] [Abstract][Full Text] [Related]
15. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
17. Hyperplastic and serrated polyps of the colorectum.
O'Brien MJ
Gastroenterol Clin North Am; 2007 Dec; 36(4):947-68, viii. PubMed ID: 17996799
[TBL] [Abstract][Full Text] [Related]
18. Frequent p53 gene mutations in serrated adenomas of the colorectum.
Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
[TBL] [Abstract][Full Text] [Related]
19. Serrated lesions of the appendix frequently harbor KRAS mutations and not BRAF mutations indicating a distinctly different serrated neoplastic pathway in the appendix.
Pai RK; Hartman DJ; Gonzalo DH; Lai KK; Downs-Kelly E; Goldblum JR; Liu X; Patil DT; Bennett AE; Plesec TP; Kuan SF; Nikiforova MN; Shadrach B; Pai RK
Hum Pathol; 2014 Feb; 45(2):227-35. PubMed ID: 24439221
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis.
Bossard C; Denis MG; Bézieau S; Bach-Ngohou K; Bourreille A; Laboisse CL; Mosnier JF
Oncol Rep; 2007 Nov; 18(5):1093-7. PubMed ID: 17914558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
